Inventor · disambiguated record
Gregor Schulz
Also filed as: SCHULZ GREGOR
9 granted patents·4 pending applications·105 citations·filing 1984–2018
87Inventor score
Top patents by PatentIndex Score
13 records- 0188US4675287AMonoclonal antibody directed to human ganglioside GD2SCRIPPS CLINIC RES·Filed 1984·Granted Jun 23, 1987·57 cites·20 claims
- 0286US10117932B2Uses of immunoconjugates targeting CD138BIOTEST AG·Filed 2012·Granted Nov 6, 2018·7 cites·46 claims
- 0386US9011864B2Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugatesSCHULZ GREGOR·Filed 2008·Granted Apr 21, 2015·19 cites·18 claims
- 0482US9289509B2Uses of immunoconjugates targeting CD138OSTERROTH FRANK·Filed 2010·Granted Mar 22, 2016·10 cites·49 claims
- 0581US9221914B2Agents targeting CD138 and uses thereofKRAUS ELMAR·Filed 2008·Granted Dec 29, 2015·6 cites·10 claims
- 0677US9387261B2Immunoconjugates targeting CD138 and uses thereofKRAUS ELMAR·Filed 2008·Granted Jul 12, 2016·4 cites·18 claims
- 0764US9995733B2Agents for treating diseaseOSTERROTH FRANK·Filed 2012·Granted Jun 12, 2018·1 cites·28 claims
- 0859US9550831B2Method for treating psoriasisAIGNER SILKE·Filed 2010·Granted Jan 24, 2017·1 cites·13 claims
- 0956US2019117770A1Uses of immunoconjugates targeting cd138BIOTEST AG·Filed 2018·Application pending·0 cites
- 1043US2017081418A1Immunoconjugates targeting cd138 and uses thereofBIOTEST AG·Filed 2016·Application pending·0 cites
- 1141US2016185854A1Agents targeting cd138 and uses thereofBIOTEST AG·Filed 2015·Application pending·0 cites
- 1234US2011229465A1Composition for treating diseaseOSTERROTH FRANK·Filed 2011·Application pending·0 cites
- 1330US9512226B2Agent for treating diseaseGERMER MATTHIAS·Filed 2010·Granted Dec 6, 2016·0 cites·34 claims
Join the waitlist — get patent alerts
Get an alert when Gregor Schulz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →